Follow
Hamdullah YANIK
Hamdullah YANIK
Verified email at hacettepe.edu.tr
Title
Cited by
Cited by
Year
New findings on autoimmune etiology of idiopathic granulomatous mastitis: serum IL-17, IL-22 and IL-23 levels of patients
M Saydam, KB Yilmaz, M Sahin, H Yanik, M Akinci, I Yilmaz, S Balas, ...
Journal of Investigative Surgery 34 (9), 993-997, 2021
502021
Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer
M Karpuz, M Silindir-Gunay, AY Ozer, SC Ozturk, H Yanik, M Tuncel, ...
European Journal of Pharmaceutical Sciences 156, 105576, 2021
392021
Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer
E Tavukcuoglu, U Horzum, H Yanik, A Uner, D Yoyen‐Ermis, SK Nural, ...
European journal of immunology 50 (12), 2067-2074, 2020
282020
Breast cancer cells and macrophages in a paracrine-juxtacrine loop
S Onal, M Turker-Burhan, G Bati-Ayaz, H Yanik, D Pesen-Okvur
Biomaterials 267, 120412, 2021
222021
Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model
S Ünal, SC Öztürk, E Bilgiç, H Yanık, P Korkusuz, Y Aktaş, JM Benito, ...
European Journal of Pharmaceutics and Biopharmaceutics 169, 168-177, 2021
182021
Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors
S Anthiya, SC Öztürk, H Yanik, E Tavukcuoglu, A Şahin, D Datta, ...
Journal of Controlled Release 357, 67-83, 2023
162023
Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes
MA Kursunel, EZ Taskiran, E Tavukcuoglu, H Yanik, F Demirag, ...
Cancer Immunology, Immunotherapy, 1-15, 2022
152022
Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier
I Seko, H Tonbul, E Tavukçuoğlu, A Şahin, S Akbas, H Yanık, SC Öztürk, ...
Journal of Drug Delivery Science and Technology 66, 102867, 2021
132021
A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer
G Tunali, H Yanik, SC Ozturk, S Demirkol-Canli, G Efthymiou, KB Yilmaz, ...
Breast Cancer Research 25 (1), 27, 2023
52023
Effector Th1 cells under PD‐1 and CTLA‐4 checkpoint blockade abrogate the upregulation of multiple inhibitory receptors and by‐pass exhaustion
U Horzum, H Yanik, EZ Taskiran, G Esendagli
Immunology 167 (4), 640-650, 2022
32022
Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination
M Hafızoğlu, AO Bas, E Tavukçuoğlu, Z Sahiner, MG Oytun, S Ulutürk, ...
Clinical Immunology Communications 2, 154-158, 2022
12022
Serum endocan levels can predict malignancy of thyroid: a prospective clinical study
M ŞAHİN, M Saydam, K YILMAZ, H Yanik, I Yilmaz, G GÜNDOĞAN, ...
Anadolu Güncel Tıp Dergisi 2 (4), 117-122, 2020
12020
Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
E Tavukcuoglu, H Yanik, M Parveen, S Uluturk, M Durusu-Tanriover, ...
Scientific Reports 13 (1), 4610, 2023
2023
Effects of transcutaneous electrical nerve stimulation on rats with post-operative ileus
Ş Balas, KB Yılmaz, S Tokgöz, M Saydam, H Yanık, E Önder, M Akıncı, ...
Turkish Journal of Trauma & Emergency Surgery 28 (10), 1382, 2022
2022
Clinical Immunology Communications
M Hafızoğlu, AO Bas, E Tavukçuoğlu, Z Sahiner, MG Oytun, S Ulutürk, ...
Clinical Immunology 2, 154-158, 2022
2022
Cytotoxicity and Biological Compatibility
E Tavukcuoglu, H Yanik, G Esendagli
Drug Delivery with Targeted Nanoparticles, 223-246, 2021
2021
Development of curcumin and docetaxel co-loaded actively targeted PLGA
I Seko, H Tonbul, E Tavukcuoglu, A Sahin, S Akbas, H Yanik, SC Ozturk, ...
2021
Design and synthesis of novel peptidomimetics for cancer immunotherapy
C Kose, E Uysal, B Yazici, Z Tugay, SI Dingis-Birgul, H Yanik, ...
2020
The system can't perform the operation now. Try again later.
Articles 1–18